Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • asthma drug

    Tag: asthma drug

    You Searched For "asthma drug"
    Cipla moves against NPPA for price fixation of asthma drugs; DOP junks plea

    Cipla moves against NPPA for price fixation of asthma drugs; DOP junks plea

    Farhat Nasim16 Jun 2019 11:44 AM IST
    New Delhi: Mumbai-based drugmaker, Cipla Limited's review petition against the Government regulatory agency, National Pharmaceutical Pricing Authority...
    Cipla, Pulmatrix join hands to co-develop Pulmazole for treating asthma

    Cipla, Pulmatrix join hands to co-develop Pulmazole for treating asthma

    Garima16 April 2019 9:40 AM IST
    Pulmazole an inhaled iSPERSE formulation of the antifungal drug itraconazole for the treatment of allergic bronchopulmonary aspergillosis (ABPA) in...
    Cipla signs over Rs 152 crore pact with Pulmatrix for new asthma drug Pulmazole

    Cipla signs over Rs 152 crore pact with Pulmatrix for new asthma drug Pulmazole

    Garima2 April 2019 9:45 AM IST
    The agreement has been signed between the company's wholly-owned subsidiary in the US, Cipla Technologies LLC with Pulmatrix Inc for investment in...
    HC Rescues Lupin on Price cap on powdered form of asthma drug

    HC Rescues Lupin on Price cap on powdered form of asthma drug

    Ruby Khatun Khatun22 April 2018 11:58 AM IST
    New Delhi: The Delhi High Court directed the Centre not to take any coercive measure against Indian pharma major Lupin Ltd which has challenged a...
    Morepen Labs gets USFDA nod for asthma drug

    Morepen Labs gets USFDA nod for asthma drug

    Ruby Khatun Khatun21 Dec 2017 2:09 PM IST
    New Delhi: Morepen Laboratories said the US health regulator has given approval to Montelukast Sodium, used in managing asthma symptoms and seasonal...
    Regeneron, Sanofi asthma drug data fails to excite investors

    Regeneron, Sanofi asthma drug data fails to excite investors

    Ruby Khatun Khatun13 Sept 2017 1:42 PM IST
    PARIS: Shares of Regeneron Inc and Sanofi SA slid on Monday after late-stage trial data for their asthma drug, dupilumab, fell short of investor...

    Popular Stories

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok